Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03611361 · ClinicalTrials.gov registry record
Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients
A clinical trial, sponsored by SpectralMD.
- Terminated
- Registry status
- 55
- Enrollment target
NCT03611361 is a clinical trial that was terminated before completion, run by SpectralMD. The registered enrollment target is 55 participants.
The verdict
NCT03611361 was terminated before completion, sponsored by SpectralMD.
- TERMINATED
- Registry status
- 55 participants
- Enrollment target
Study Summary
This is a proof-of-concept study to collect images to train a CADe algorithm to predict the correct level of amputation in individuals scheduled for amputation secondary to PAD.
Interventions
- DEVICE SpectralMD DeepView Wound Imaging System 2.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-11-18 |
| Est. Completion | 2020-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03611361
The ClinicalTrials.gov registry entry for NCT03611361 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SpectralMD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SpectralMD DeepView Wound Imaging System 2.0 is the first listed.
NCT03611361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03611361 about?
NCT03611361 is a clinical study titled "Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients". This is a proof-of-concept study to collect images to train a CADe algorithm to predict the correct level of amputation in individuals scheduled for amputation secondary to PAD.
What is the current status of trial NCT03611361?
This trial is currently terminated. The enrollment target is 55 participants. The study started on 2015-11-18. Estimated completion is 2020-12.
What interventions are being tested in trial NCT03611361?
The interventions under investigation include: SpectralMD DeepView Wound Imaging System 2.0 (DEVICE).
Who is sponsoring clinical trial NCT03611361?
This trial is sponsored by SpectralMD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.